Document Detail


Short- and long-term (six-year) hemodynamic effects of labetalol in essential hypertension.
MedLine Citation:
PMID:  6638038     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The acute blood pressure lowering effect of intravenous labetalol (0.2 to 0.8 mg/kg) was studied in 11 patients with severe hypertension. The blood pressure was reduced by 22 percent partly due to a decrease in total peripheral resistance (-14 percent) and partly due to a reduction in cardiac output (-10 percent). Stroke volume was unchanged. Fifteen patients with moderate essential hypertension were studied at rest and during exercise before and after one and six years of labetalol therapy. Blood pressure was reduced approximately 22 percent at rest as well as during exercise, mainly due to a reduction in total peripheral resistance. However, after one year, cardiac index was reduced 10 to 14 percent (p less than 0.01) at rest (sitting) and during exercise due to a reduction in heart rate not compensated for by an increase in stroke volume. During the next five years, blood pressure control was maintained, but cardiac index tended to increase and was not significantly reduced in any situation six years after treatment was started. Total peripheral resistance decreased significantly and was reduced 15 to 20 percent (p less than 0.01) after six years. Stroke index increased about 10 to 15 percent (p less than 0.01). These alterations are the opposite of what is seen in untreated hypertensive patients restudied after 10 and 17 years. The normalization of central hemodynamics could reflect the regression of structural changes in the heart and in the resistance vessels.
Authors:
P Lund-Johansen
Related Documents :
8507448 - Hydrocortisone-induced hypertension in men. the role of cardiac output.
2358558 - Comparison of a modified fick method with thermodilution for determining cardiac output...
4051458 - Cardiac dysfunction during status epilepticus in the neonatal pig.
513498 - Hemodynamic changes during sequential ultrafiltration and dialysis.
15187518 - Experimental spinal cord ischemia: model characterization and improved outcome with art...
24355938 - The role of equilibrium volume and magnetism on the stability of iron phases at high pr...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American journal of medicine     Volume:  75     ISSN:  0002-9343     ISO Abbreviation:  Am. J. Med.     Publication Date:  1983 Oct 
Date Detail:
Created Date:  1983-12-17     Completed Date:  1983-12-17     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0267200     Medline TA:  Am J Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  24-31     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Blood Pressure
Cardiac Output
Ethanolamines / therapeutic use*
Female
Hemodynamics*
Humans
Hypertension / diagnosis,  drug therapy*,  physiopathology
Labetalol / therapeutic use*
Male
Middle Aged
Stroke Volume
Vascular Resistance
Chemical
Reg. No./Substance:
0/Ethanolamines; 36894-69-6/Labetalol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Developing a data-collection system.
Next Document:  Systemic, pulmonary, and coronary hemodynamic effects of labetalol in hypertensive subjects.